Eupraxia Pharmaceuticals Inc EPRX"-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 04/16/21 EDT
1.00quote price arrow down-0.02 (-1.96%)
Volume
1,000
52 week range
0.80 - 1.40

...

Loading . . .
  • Open1.00
  • Day High1.00
  • Day Low1.00
  • Prev Close1.00
  • 52 Week High1.40
  • 52 Week High Date03/15/21
  • 52 Week Low0.80
  • 52 Week Low Date03/29/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open1.00
  • Day High1.00
  • Day Low1.00
  • Prev Close1.00
  • 52 Week High1.40
  • 52 Week High Date03/15/21
  • 52 Week Low0.80
  • 52 Week Low Date03/29/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Eupraxia Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company with a drug delivery technology platform. The Company's lead product candidate, EP-104IAR consists of development of drugs for the treatment of pain due to osteoarthritis of the knee. In addition to EP-104IAR, the Company is developing a pipeline of earlier-stage long-acting formulations. Its pipeline candidates include a range of drugs for indications such as post-surgical pain (EP-105), and...
Address
2067 Cadboro Bay Road, #201
Victoria, BC
V8R 5G4
Canada